Epiphora Clinical Trial
Official title:
A Comparison Between Placement of Three Interrupted Sutures After Triangular Three-snip Punctoplasty vs Conventional Triangular Three-snip Punctoplasty for Treatment of Lower Punctal Stenosis
Verified date | December 2020 |
Source | Menoufia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
a prospective randomized study conducted upon 40 eyes of 24 patients with lower punctual stenosis (grade 1 or 2 according to Kashkouli scale) attending at Menoufia University hospitals and Kafr Elsheikh ophthalmic eye center. The upper punctum and canaliculus were patent. All patients were complaining of epiphora and had a thorough ophthalmological examination including dye disappearance test, and slit-lamp examination. A Nettelship dilator is used to enlarge the stenotic lacrimal punctum. A single blade of a small Westcott spring scissor or Vannus scissor is placed within the ampulla of the lacrimal canaliculus, with the remaining blade placed on the conjunctival surface of the posterior aspect of the eyelid. The first vertical snip is made at the vertical canaliculus. The second vertical snip is made from the edge of the first snip to create a flap. The final horizontal snip was made at the base. The triangular flap is removed and three sutures are placed, in an interrupted manner, at the posterior wall of the ampulla using 10-0 nylon. The sutures are removed 1 week after the surgery. Topical moxifloxacin 0.5% eye drops and fluorometholone 0.1% eye drops were used four times daily for one week.Patients were then followed up for 6 months after the surgery.
Status | Active, not recruiting |
Enrollment | 24 |
Est. completion date | December 23, 2020 |
Est. primary completion date | December 20, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 17 Years and older |
Eligibility | Inclusion Criteria: - primary acquired lower punctal stenosis grade 1 or 2 according to Kashkouli et al. , patent upper punctum and both canaliculi as well as patent nasolacrimal duct , normal lower eyelid margin position Exclusion Criteria: - Patients with Congenital punctal stenosis, Acute conjunctival allergic punctal stenosis, Punctal stenosis associated with radiotherapy, Lid malposition, Canalicular, lacrimal sac and nasolacrimal duct obstruction revealed after syringing , Previous eyelid or lacrimal drainage system surgery, Blepharitis and ocular surface disorders, Patients with dry eye were excluded. |
Country | Name | City | State |
---|---|---|---|
Egypt | MenoufiaU | Shibin Al Kawm |
Lead Sponsor | Collaborator |
---|---|
Menoufia University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Degree of improvement of epiphora by Munk score | Measurement of improvement of epiphora by use of Munk score as follow :
Grade 0 : No Epiphora. Grade 1 : Occasional epiphora requiring drying or dabbing less than twice a day. Grade 2 : Epiphora requiring dabbing two to four times per day. Grade 3 : Epiphora requiring dabbing five to ten times per day. Grade 4 : Epiphora requiring dabbing more than ten times daily or constant tearing. |
6 months | |
Primary | Degree of improvement of lacrimal drainage by Dye disappearance test | Performed by putting a drop of 2% fluorescein sodium in the conjunctival sac followed by assessment after 5 minutes of the remaining dye in the tear meniscus. Results were graded according to the following scale
Grade 1 : <3 minutes Grade 2 : 3-5 minutes Grade 3 : >5 minutes |
6 months | |
Primary | Slit lamp assesment of the state of the lower punctum | Slit lamp examination of the lower punctum and its grading according to Kashkouli scale as follows:
Grade 0 : No punctum (agenesis) Grade 1 : Papilla is covered with a membrane (difficult to recognize) Grade 2 : Less than normal size, but recognizable Grade 3 : Normal Grade 4 : Small slit (<2 mm) Grade 5 : Large slit (=2 mm) |
6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04833452 -
Comparative Study Between Wide and Narrow Fenstrum Endoscopic DCR
|
N/A | |
Completed |
NCT02240615 -
The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora
|
Phase 0 | |
Suspended |
NCT03705000 -
SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction
|
N/A | |
Completed |
NCT01010659 -
The Safety and Efficacy of Lacrimal Silicone Intubation for the Management of Epiphora
|
Phase 4 | |
Recruiting |
NCT05663684 -
Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?
|
Phase 4 | |
Terminated |
NCT04229771 -
Does Topical Ophthalmic Anesthetic Prior to Probing and Irrigation Decrease Pain?
|
Phase 4 | |
Active, not recruiting |
NCT02849093 -
Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome.
|
N/A | |
Withdrawn |
NCT00824811 -
Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel
|
Phase 2 | |
Completed |
NCT00266838 -
Prevention of Docetaxel Induced Dacryostenosis
|
Phase 1 | |
Completed |
NCT03731143 -
Management of Lower Punctal Stenosis.
|
N/A | |
Completed |
NCT01282541 -
Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora
|
Phase 2 | |
Completed |
NCT02503956 -
Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients
|
N/A | |
Completed |
NCT04637633 -
Topical Cyclosporine-A for Management of Epiphora
|
Phase 2/Phase 3 | |
Withdrawn |
NCT03266081 -
Bupivacaine Epiphora Trial
|
Phase 2 | |
Completed |
NCT01766232 -
Lacrimal Drainage Resistance Study
|
N/A |